日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer

影响年轻乳腺癌女性接受辅助内分泌治疗5年坚持率的因素

期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2024.103765
Pagan, Eleonora; Ruggeri, Monica; Bianco, Nadia; Bucci, Eraldo Oreste; Graffeo, Rossella; Borner, Markus; Giordano, Monica; Gianni, Lorenzo; Rabaglio, Manuela; Freschi, Andrea; Cretella, Elisabetta; Seles, Elena; Farolfi, Alberto; Simoncini, Edda; Ciccarese, Mariangela; Rauch, Daniel; Favaretto, Adolfo; Honecker, Friedemann; Berardi, Rossana; Franzetti-Pellanda, Alessandra; Gelber, Shari; Partridge, Ann H; Goldhirsch, Aron; Bagnardi, Vincenzo; Pagani, Olivia; Ribi, Karin
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Anticancer Activity of the Marine Triterpene Glycoside Cucumarioside A(2)-2 in Human Prostate Cancer Cells

海洋三萜糖苷Cucumarioside A(2)-2在人前列腺癌细胞中的抗癌活性

期刊:Marine Drugs
影响因子:5.4
doi:10.3390/md22010020
Menchinskaya, Ekaterina S; Dyshlovoy, Sergey A; Venz, Simone; Jacobsen, Christine; Hauschild, Jessica; Rohlfing, Tina; Silchenko, Aleksandra S; Avilov, Sergey A; Balabanov, Stefan; Bokemeyer, Carsten; Aminin, Dmitry L; von Amsberg, Gunhild; Honecker, Friedemann
肿瘤
肿瘤免疫
Human
细胞生物学
前列腺癌
发表日期：2023
文献求助 收藏

Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors

3p25.3染色体扩增与顺铂耐药性相关，并且是男性恶性生殖细胞肿瘤预后不良的独立预测因子。

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.21.02809
Timmerman, Dennis M; Eleveld, Thomas F; Sriram, Sruthi; Dorssers, Lambert C J; Gillis, Ad J M; Schmidtova, Silvia; Kalavska, Katarina; van de Werken, Harmen J G; Oing, Christoph; Honecker, Friedemann; Mego, Michal; Looijenga, Leendert H J
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Marine Compounds and Cancer: Updates 2022

海洋化合物与癌症：2022 年最新进展

期刊:Marine Drugs
影响因子:5.4
doi:10.3390/md20120759
Dyshlovoy, Sergey A; Honecker, Friedemann
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Marine Drugs Acting as Autophagy Modulators

海洋药物作为自噬调节剂

期刊:Marine Drugs
影响因子:5.4
doi:10.3390/md18010053
Dyshlovoy, Sergey A; Honecker, Friedemann
Autophagy
自噬
发表日期：2020
文献求助 收藏

Marine Compounds and Cancer: Updates 2020

海洋化合物与癌症：2020 年最新进展

期刊:Marine Drugs
影响因子:5.4
doi:10.3390/md18120643
Dyshlovoy, Sergey A; Honecker, Friedemann
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors.

HDAC抑制剂贝利司他和帕比司他治疗顺铂敏感和顺铂耐药睾丸生殖细胞肿瘤的疗效

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers12102903
Lobo João, Guimarães-Teixeira Catarina, Barros-Silva Daniela, Miranda-Gonçalves Vera, Camilo Vânia, Guimarães Rita, Cantante Mariana, Braga Isaac, Maurício Joaquina, Oing Christoph, Honecker Friedemann, Nettersheim Daniel, Looijenga Leendert Hj, Henrique Rui, Jerónimo Carmen
细胞生物学
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Marine Compounds and Cancer: The First Two Decades of XXI Century

海洋化合物与癌症：21世纪头二十年

期刊:Marine Drugs
影响因子:5.4
doi:10.3390/md18010020
Dyshlovoy, Sergey A; Honecker, Friedemann
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group

依维莫司治疗多次复发或顺铂难治性生殖细胞肿瘤患者：德国睾丸癌研究组一项II期单臂开放标签多中心试验（RADIT）的结果

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-018-2752-z
Fenner, Martin; Oing, Christoph; Dieing, Annette; Gauler, Thomas; Oechsle, Karin; Lorch, Anja; Hentrich, Marcus; Kopp, Hans-Georg; Bokemeyer, Carsten; Honecker, Friedemann
细胞生物学
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

Marine Compounds and Autophagy: Beginning of a New Era

海洋化合物与自噬：新时代的开端

期刊:Marine Drugs
影响因子:5.4
doi:10.3390/md16080260
Dyshlovoy, Sergey A; Honecker, Friedemann
Autophagy
自噬
发表日期：2018
文献求助 收藏